Fibrilación auricular

  1. Sánchez Borque, P. 1
  2. Bravo Calero, L. 1
  3. Miracle Blanco, A. 1
  4. García Talavera, C. 1
  5. Porta Sánchez, A. 2
  6. Cabrera Rodríguez, J.A. 2
  7. Rubio Campal, J.M. 1
  1. 1 Servicio de Cardiología, Hospital Universitario Fundación Jiménez Díaz. Universidad Autónoma de Madrid, Madrid, España
  2. 2 Servicio de Cardiología, Hospital Universitario Quirónsalud Madrid. Universidad Europea de Madrid. Pozuelo de Alarcón, Madrid, España
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Año de publicación: 2021

Título del ejemplar: Enfermedades cardiovasculares (XI)

Serie: 13

Número: 45

Páginas: 2617-2626

Tipo: Artículo

DOI: 10.1016/J.MED.2021.11.001 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Medicine: Programa de Formación Médica Continuada Acreditado

Resumen

La fibrilación auricular y el flutter o aleteo auricular son dos tipos de arritmias muy frecuentes en la población general, tanto en pacientes con cardiopatía estructural como en pacientes sin ella. Aunque desde el punto de vista fisiopatológico son entidades diferentes, comparten muchas características entre sí (factores predisponentes, riesgo cardioembólico, tratamiento) y, en muchas ocasiones, ambas arritmias pueden coexistir en un mismo paciente.

Referencias bibliográficas

  • Arbelo E, Aktaa S, Bollmann A, D’Avila A, Drossart I, Dwight J, Quality indicators for the care and outcomes of adults with atrial fibrillation. Europace. 2021;23(4):494-5.
  • Brambatti M, Connolly SJ, Gold MR, Morillo CA, Capucci A, Muto C, ASSERT Investigators. Temporal relationship bet-ween subclinical atrial fibrillation and embolic events. Circulation 2014;129:2094-29.
  • Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Europace. 2018;20:157-208.
  • Camm A, Lüscher T, Maurer G, Serruys P, eds. The ESC Textbook of cardiovascular medicine. 3ª ed. Oxford University Press; 2018.
  • Camm AJ, Simantirakis E, Goette A, Lip GY, Vardas P, Calvert M. Atrial highrate episodes and stroke prevention. Europace. 2017;19:169-79.
  • Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A. RE-LY Steering. Committee Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-51.
  • Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL. ENGAGE AF-TIMI Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093-104.
  • Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Europace. 2016;18:1455-90.
  • Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M. ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981-92.
  • Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659-66.
  • Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström Lundqvist C. ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498.
  • Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Europace. 2018;20:157-208.
  • Michaud G, Stevenson W. Atrial fibrillation. Engl J Med. 2021;384:353-61.
  • Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W. ROC-KET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883-91.
  • Proietti M, Romiti GF, Olshansky B, Lane DA, Lip GYH. Improved outcomes by integrated care of anticoagulated patients with atrial fibrillation using the simple ABC (Atrial Fibrillation Better Care) Pathway. Am J Med. 2018;131:1359-69.
Fuente de los datos: Dialnet